<code id='D3B7C58CA5'></code><style id='D3B7C58CA5'></style>
    • <acronym id='D3B7C58CA5'></acronym>
      <center id='D3B7C58CA5'><center id='D3B7C58CA5'><tfoot id='D3B7C58CA5'></tfoot></center><abbr id='D3B7C58CA5'><dir id='D3B7C58CA5'><tfoot id='D3B7C58CA5'></tfoot><noframes id='D3B7C58CA5'>

    • <optgroup id='D3B7C58CA5'><strike id='D3B7C58CA5'><sup id='D3B7C58CA5'></sup></strike><code id='D3B7C58CA5'></code></optgroup>
        1. <b id='D3B7C58CA5'><label id='D3B7C58CA5'><select id='D3B7C58CA5'><dt id='D3B7C58CA5'><span id='D3B7C58CA5'></span></dt></select></label></b><u id='D3B7C58CA5'></u>
          <i id='D3B7C58CA5'><strike id='D3B7C58CA5'><tt id='D3B7C58CA5'><pre id='D3B7C58CA5'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:9
          Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT
          Alex Hogan/STAT

          Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

          NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

          advertisement

          Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes
          Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

          EricRisberg/APTwodominantBlueCrossBlueShieldcompaniesinCaliforniaintentionallyunderreportedpremiumso

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Custom gene therapy hints at new path for rare disease treatments

          AdobeWhenTimothyYudevelopedmilasen,acustomdrugforayounggirlnamedMilawithBattendisease,heignitedaspar